Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of a Proteasome Inhibitor on Cardiomyocytes in a Pressure-Overload Hypertrophy Rat Model: An Animal Study

  • Kim, In-Sub (Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine) ;
  • Jo, Won-Min (Department of Thoracic and Cardiovascular Surgery, Korea University Ansan Hospital, Korea University College of Medicine)
  • Received : 2016.08.19
  • Accepted : 2016.12.29
  • Published : 2017.06.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The ubiquitin-proteasome system (UPS) is an important pathway of proteolysis in pathologic hypertrophic cardiomyocytes. We hypothesize that MG132, a proteasome inhibitor, might prevent hypertrophic cardiomyopathy (CMP) by blocking the UPS. Nuclear factor kappa-light-chain-enhancer of activated B cells ($NF-{\kappa}B$) and androgen receptor (AR) have been reported to be mediators of CMP and heart failure. This study drew upon pathophysiologic studies and the analysis of $NF-{\kappa}B$ and AR to assess the cardioprotective effects of MG132 in a left ventricular hypertrophy (LVH) rat model. Methods: We constructed a transverse aortic constriction (TAC)-induced LVH rat model with 3 groups: sham (TAC-sham, n=10), control (TAC-cont, n=10), and MG132 administration (TAC-MG132, n=10). MG-132 (0.1 mg/kg) was injected for 4 weeks in the TAC-MG132 group. Pathophysiologic evaluations were performed and the expression of AR and $NF-{\kappa}B$ was measured in the left ventricle. Results: Fibrosis was prevalent in the pathologic examination of the TAC-cont model, and it was reduced in the TAC-MG132 group, although not significantly. Less expression of AR, but not $NF-{\kappa}B$, was found in the TAC-MG132 group than in the TAC-cont group (p<0.05). Conclusion: MG-132 was found to suppress AR in the TAC-CMP model by blocking the UPS, which reduced fibrosis. However, $NF-{\kappa}B$ expression levels were not related to UPS function.

Keywords

References

  1. Ciechanover A, Finley D, Varshavsky A. Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell 1984;37:57-66. https://doi.org/10.1016/0092-8674(84)90300-3
  2. Hershko A, Heller H, Elias S, Ciechanover A. Components of ubiquitin-protein ligase system: resolution, affinity purification, and role in protein breakdown. J Biol Chem 1983;258:8206-14.
  3. Ding Q, Dimayuga E, Markesbery WR, Keller JN. Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J 2006;20:1055-63. https://doi.org/10.1096/fj.05-5495com
  4. Doll D, Sarikas A, Krajcik R, Zolk O. Proteomic expression analysis of cardiomyocytes subjected to proteasome inhibition. Biochem Biophys Res Commun 2007;353:436-42. https://doi.org/10.1016/j.bbrc.2006.12.039
  5. Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 1998;98:256-61. https://doi.org/10.1161/01.CIR.98.3.256
  6. Lin HK, Altuwaijri S, Lin WJ, Kan PY, Collins LL, Chang C. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J Biol Chem 2002;277: 36570-6. https://doi.org/10.1074/jbc.M204751200
  7. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986;46: 705-16. https://doi.org/10.1016/0092-8674(86)90346-6
  8. Chandel NS, Trzyna WC, McClintock DS, Schumacker PT. Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J Immunol 2000;165:1013-21. https://doi.org/10.4049/jimmunol.165.2.1013
  9. Gupta S, Sen S. Role of the NF-kappaB signaling cascade and NF-kappaB-targeted genes in failing human hearts. J Mol Med (Berl) 2005;83:993-1004. https://doi.org/10.1007/s00109-005-0691-z
  10. Green CJ, Knight J, Precious S, Simpkin S. Ketamine alone and combined with diazepam or xylazine in laboratory animals: a 10 year experience. Lab Anim 1981;15:163-70. https://doi.org/10.1258/002367781780959107
  11. Rivard AL, Simura KJ, Mohammed S, et al. Rat intubation and ventilation for surgical research. J Invest Surg 2006; 19:267-74. https://doi.org/10.1080/08941930600778297
  12. Feng B, Li BY, Nauman EA, Schild JH. Theoretical and electrophysiological evidence for axial loading about aortic baroreceptor nerve terminals in rats. Am J Physiol Heart Circ Physiol 2007;293:H3659-72. https://doi.org/10.1152/ajpheart.00712.2007
  13. Ryu SM, Kim HJ, Cho KR, Jo WM. Myocardial protective effect of tezosentan, an endothelin receptor antagonist, for ischemia-reperfusion injury in experimental heart failure models. J Korean Med Sci 2009;24:782-8. https://doi.org/10.3346/jkms.2009.24.5.782
  14. Janicki JS, Brower GL. The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail 2002;8(6 Suppl):S319-25. https://doi.org/10.1054/jcaf.2002.129260
  15. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006;25:6680-4. https://doi.org/10.1038/sj.onc.1209954
  16. Tanaka K. The proteasome: overview of structure and functions. Proc Jpn Acad Ser B Phys Biol Sci 2009;85:12-36. https://doi.org/10.2183/pjab.85.12
  17. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature 2003;426:895-9. https://doi.org/10.1038/nature02263
  18. Willis MS, Schisler JC, Patterson C. Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease. Future Cardiol 2008;4:65-75. https://doi.org/10.2217/14796678.4.1.65
  19. Drews O, Taegtmeyer H. Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies. Antioxid Redox Signal 2014;21:2322-43. https://doi.org/10.1089/ars.2013.5823
  20. Lee H, Park J, Kim EE, Yoo YS, Song EJ. Proteasome inhibitors attenuated cholesterol-induced cardiac hypertrophy in H9c2 cells. BMB Rep 2016;49:270-5. https://doi.org/10.5483/BMBRep.2016.49.5.187
  21. Chen B, Ma Y, Meng R, et al. MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals. Acta Biochim Biophys Sin (Shanghai) 2010;42:253-8. https://doi.org/10.1093/abbs/gmq012
  22. Stansfield WE, Moss NC, Willis MS, Tang R, Selzman CH. Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury. Ann Thorac Surg 2007;84:120-5. https://doi.org/10.1016/j.athoracsur.2007.02.049
  23. Luss H, Schmitz W, Neumann J. A proteasome inhibitor confers cardioprotection. Cardiovasc Res 2002;54:140-51. https://doi.org/10.1016/S0008-6363(02)00232-8
  24. Pye J, Ardeshirpour F, McCain A, et al. Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol 2003;284:H919-26. https://doi.org/10.1152/ajpheart.00851.2002
  25. Stangl K, Gunther C, Frank T, et al. Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection. Biochem Biophys Res Commun 2002;291: 542-9. https://doi.org/10.1006/bbrc.2002.6476
  26. Gupta S, Young D, Maitra RK, et al. Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol 2008;375:637-49. https://doi.org/10.1016/j.jmb.2007.10.006
  27. Wang Y, Sun W, Du B, et al. Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-${\kappa}B$. Am J Physiol Heart Circ Physiol 2013;304:H567-78. https://doi.org/10.1152/ajpheart.00650.2012
  28. Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 2000;12:85-98. https://doi.org/10.1006/smim.2000.0210
  29. Nelson DE, Ihekwaba AE, Elliott M, et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 2004;306:704-8. https://doi.org/10.1126/science.1099962
  30. Ma Y, Chen B, Liu D, et al. MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-${\kappa}B$/TGF${\beta}1$ pathway. Biochem Pharmacol 2011;81:1228-36. https://doi.org/10.1016/j.bcp.2011.03.009
  31. Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocr Rev 1987;8:1-28. https://doi.org/10.1210/edrv-8-1-1
  32. Ma Y, Chen Y, Yang Y, et al. Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression. Biochem Pharmacol 2013;85:223-33. https://doi.org/10.1016/j.bcp.2012.10.025
  33. Min TJ, Jo WM, Shin SY, Lim HE. The protective effect of heat shock protein 70 (Hsp70) in atrial fibrillation in various cardiomyopathy conditions. Heart Vessels 2015;30: 379-85. https://doi.org/10.1007/s00380-014-0521-8

Cited by

  1. Exercise Mediated Nrf2 Signaling Protects the Myocardium From Isoproterenol-Induced Pathological Remodeling vol.6, pp.None, 2017, https://doi.org/10.3389/fcvm.2019.00068
  2. 3D-printed cranial models simulating operative field depth for microvascular training in neurosurgery vol.12, pp.None, 2017, https://doi.org/10.25259/sni_849_2020